Dr. Mark Asher Schusterman II, MD

Dr. Schusterman practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Dr. Schusterman's NPI, 1366872020, was assigned on November 17, 2013. Dr. Schusterman graduated from UTMB Health in 2013. Dr. Schusterman holds Texas license S4680.

Dr. Schusterman's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Dr. Schusterman's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Dr. Schusterman is also affiliated with Houston Methodist Willowbrook Hospital. The medical group on file is Houston Methodist Institute for Reconstructive Surgery. Dmand AI also links Dr. Schusterman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schusterman practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Schusterman's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Schusterman is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Schusterman's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists breast reconstruction, breast surgery, chronic skin ulcer and lymphedema among the conditions Dr. Schusterman treats.

CMS data shows 42 Medicare services from Dr. Schusterman across 2 procedure codes in 2024, all of them office visits, for 42 Medicare patients. Medicare paid $3,173 for them. Every service was in an office.

CMS counts 42 Medicare patients who saw Dr. Schusterman in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schusterman's median patient age at 58, with 83% women.

In 2024, Dr. Schusterman wrote 81 Medicare Part D claims for 28 patients. 100% of them were for generic drugs. CMS names the drug for 63 of them, across 3 drugs with 11 or more claims each, at $815 in total drug cost. In 2023, CMS named 88 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Schusterman for performance year 2024, reported as part of a group. Dr. Schusterman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of mastectomy by Dr. Schusterman, more than 79% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Schusterman, published from 2017 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Mammaplasty, Breast Neoplasms and Mastectomy. Dr. Schusterman has published most often in Plast Reconstr Surg Glob Open. Dr. Schusterman's most frequent co-authors are Francesco Maria Egro, MBCHB, MS, Michael L. Gimbel and Wesley Nicholas Sivak.

CMS Open Payments shows 101 general payments to Dr. Schusterman from 27 drug and device companies from 2016 to 2025. Debt forgiveness make up the largest share, 82% of the total. Johnson & Johnson Health Care Systems Inc. paid the most, $22,954.

Dr. Schusterman graduated from UTMB Health in 2013.

Dr. Schusterman is in network with 4 carriers, including Aetna, Humana and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.